CorVista System with PH Add-On vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CorVista System with PH Add-On

by CorVista Health

iPredict Eye Screening

by iHealthScreen

AI Verdict

Tool A is designed for non-invasive diagnosis of coronary artery disease and pulmonary hypertension by analyzing cardiac and hemodynamic signals. In contrast, Tool B primarily screens for ophthalmic conditions like AMD and DR through retinal imaging, though it also provides risk prediction for systemic diseases such as heart attack. While both leverage AI and touch upon cardiovascular health, their core diagnostic targets and methodologies are distinct.

Choose CorVista System with PH Add-On if…

Choose the CorVista System with PH Add-On if you require a rapid, non-invasive, point-of-care diagnostic solution for assessing coronary artery disease and pulmonary hypertension. This tool is ideal for situations where immediate cardiovascular insights are crucial without the need for radiation, contrast agents, injections, fasting, or exercise.

View CorVista System with PH Add-On →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if your primary need is efficient, AI-powered screening for common eye diseases like AMD, Diabetic Retinopathy, and Glaucoma, particularly in primary care or telemedicine settings. This platform also offers the unique advantage of providing risk predictions for systemic conditions such as stroke and heart attack, integrating seamlessly with existing EHR systems.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CorVista System with PH Add-On	iPredict Eye Screening
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based, point-of-care system.	Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CorVista System with PH Add-On	iPredict Eye Screening
Product Name	CorVista System with PH Add-On	iPredict Eye Screening
Primary Diagnostic Focus	Rapid assessment of coronary artery disease and pulmonary hypertension	AI-powered screening for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and risk prediction for systemic diseases like stroke and heart attack
Target Medical Specialties	Cardiology, Internal Medicine, Pulmonology	Family Medicine, Internal Medicine, Ophthalmology
Core Technology/Method	Non-invasive, point-of-care AI diagnostic platform using machine-learned algorithms to analyze cardiac and hemodynamic signals (no radiation, contrast, injections, fasting, or exercise)	AI-powered screening tool utilizing an Image Analyzer for Retinal Vessel, Retinal Pathology, and OCT Inspector
Result Turnaround Time	Rapid results available within minutes	Test completed in less than 5 minutes, report in under 60 seconds

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and iPredict Eye Screening.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary diagnostic capabilities of each tool?

The CorVista System with PH Add-On is an AI diagnostic platform for rapid assessment of coronary artery disease (CAD) and pulmonary hypertension (PH). In contrast, iPredict Eye Screening is an AI-powered screening tool for age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, also offering risk prediction for systemic diseases like stroke and heart attack.

How do the patient experience and diagnostic methods differ between the CorVista System and iPredict Eye Screening?

The CorVista System is non-invasive, point-of-care, and analyzes cardiac and hemodynamic signals using machine-learned algorithms, requiring no radiation, contrast agents, injections, fasting, or exercise. iPredict Eye Screening is also non-invasive, utilizing AI-powered screening through retinal imaging, with the test completed in less than 5 minutes.

Which medical specialties are these tools primarily designed for?

The CorVista System with PH Add-On is intended for cardiology, internal medicine, and pulmonology. iPredict Eye Screening is designed for family medicine, internal medicine, and ophthalmology.

How do these tools integrate with existing clinical workflows, particularly regarding EHR and telemedicine?

The CorVista System is cloud-based, with results accessible via a secure web portal. iPredict Eye Screening integrates with Electronic Health Record (EHR) solutions and AI-based telemedicine services.

What is the typical turnaround time for results for each system?

The CorVista System provides rapid results within minutes. iPredict Eye Screening completes the test in less than 5 minutes, with a report available in under 60 seconds.

What are the key differences in the non-invasive approach of each system?

The CorVista System uses machine-learned algorithms to analyze cardiac and hemodynamic signals without requiring radiation, contrast agents, injections, fasting, or exercise. iPredict Eye Screening employs AI-based screening through retinal imaging, which is non-invasive and easy to operate.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform